Litigation Details for Radius Health, Inc. v. Orbicular Pharmaceutical Technologies Private Limited (D. Mass. 2022)
✉ Email this page to a colleague
Radius Health, Inc. v. Orbicular Pharmaceutical Technologies Private Limited (D. Mass. 2022)
Docket | ⤷ Try a Trial | Date Filed | 2022-09-20 |
Court | District Court, D. Massachusetts | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gaylore Stearns |
Jury Demand | Referred To | ||
Patents | 7,803,770; 8,148,333; 8,748,382 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Radius Health, Inc. v. Orbicular Pharmaceutical Technologies Private Limited
Details for Radius Health, Inc. v. Orbicular Pharmaceutical Technologies Private Limited (D. Mass. 2022)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2023-08-04 | 42 | Memorandum & Order | infringing United States Patent Nos. RE49,444 (the ’444 patent), 8,148,333 (the ’333 patent), 8,748,382 (the …the ’382 patent), and 10,996,208 (the ’208 patent). Before the court are the parties’ briefs on claim …related patents, the court is not persuaded. Nothing within the cited language from U.S. Patent No. 7,…August 1, 2023. THE PATENTS Abaloparatide is a parathyroid hormone-related…bone mass and quality. The ’333, ’382, and ’444 patents Case 1:22-cv-11546-RGS Document 42 Filed | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |